Nephropathy in a Child with Severe Recessive Dystrophic Epidermolysis Bullosa Treated with Cyclophosphamide: A Case Report

Long-term inflammation and recurrent skin infection in recessive dystrophic epidermolysis bullosa (RDEB) are associated with the presence of immunoglobulin A (IgA)-containing immune complexes in the glomerulus. Only eight pediatric RDEB cases with IgA nephropathy (IgAN) have been documented in Engli...

Full description

Bibliographic Details
Main Authors: Cahyani Gita Ambarsari, Retno Palupi-Baroto, Fira Alyssa Gabriella Sinuraya, Elvi Suryati, Etty Widyastuti, Suci Widhiati
Format: Article
Language:English
Published: Karger Publishers 2023-07-01
Series:Case Reports in Nephrology and Dialysis
Subjects:
Online Access:https://beta.karger.com/Article/FullText/530875
_version_ 1797745926574440448
author Cahyani Gita Ambarsari
Retno Palupi-Baroto
Fira Alyssa Gabriella Sinuraya
Elvi Suryati
Etty Widyastuti
Suci Widhiati
author_facet Cahyani Gita Ambarsari
Retno Palupi-Baroto
Fira Alyssa Gabriella Sinuraya
Elvi Suryati
Etty Widyastuti
Suci Widhiati
author_sort Cahyani Gita Ambarsari
collection DOAJ
description Long-term inflammation and recurrent skin infection in recessive dystrophic epidermolysis bullosa (RDEB) are associated with the presence of immunoglobulin A (IgA)-containing immune complexes in the glomerulus. Only eight pediatric RDEB cases with IgA nephropathy (IgAN) have been documented in English-language literature. Most RDEB patients with IgAN progress to kidney failure within 5 years of diagnosis, indicating that these patients may require more intensive early treatment compared to those with primary IgAN. However, diagnosing IgAN in RDEB cases with severe cutaneous manifestations can be challenging. Herein, we report a rare case of nephropathy in an 11-year-old boy with severe RDEB and a frameshift mutation on the COL7A1 gene, which may manifest as kidney disorders. He presented with persistent hematuria and progressing proteinuria. A presumptive IgAN diagnosis was based on clinical features and increased IgA serum levels, as kidney biopsy was refused by his parents. Nephrotic-range proteinuria persisted despite initial steroid and lisinopril treatment. Monthly intravenous cyclophosphamide (IV CPA; 500 mg/m2) led to proteinuria remission and preservation of kidney function for 2 years posttreatment. We conclude that COL7A1 mutations may result in extracutaneous manifestations, including kidney disorders. The association between IgA-containing immune complex deposits in the glomerulus and recurrent skin infection in RDEB may indicate IgAN, particularly when kidney biopsy is infeasible due to severe skin manifestations. In our case, positive results with IV CPA suggest further investigation is needed to explore its potential role in non-rapidly progressing IgAN in children with RDEB.
first_indexed 2024-03-12T15:29:53Z
format Article
id doaj.art-c1f59dde3eab49f3961197aecdb1c836
institution Directory Open Access Journal
issn 2296-9705
language English
last_indexed 2024-03-12T15:29:53Z
publishDate 2023-07-01
publisher Karger Publishers
record_format Article
series Case Reports in Nephrology and Dialysis
spelling doaj.art-c1f59dde3eab49f3961197aecdb1c8362023-08-10T08:11:07ZengKarger PublishersCase Reports in Nephrology and Dialysis2296-97052023-07-01131758310.1159/000530875530875Nephropathy in a Child with Severe Recessive Dystrophic Epidermolysis Bullosa Treated with Cyclophosphamide: A Case ReportCahyani Gita Ambarsari0https://orcid.org/0000-0003-0387-1031Retno Palupi-Baroto1Fira Alyssa Gabriella Sinuraya2Elvi Suryati3Etty Widyastuti4Suci Widhiati5Department of Child Health, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, IndonesiaDepartment of Child Health, Faculty of Medicine, Public Health and Nursing Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta, IndonesiaDepartment of Child Health, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, IndonesiaDepartment of Child Health, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, IndonesiaPuri Betik Hati Women and Children Hospital, Bandar Lampung, IndonesiaDepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Sebelas Maret, Dr. Moewardi Hospital, Surakarta, IndonesiaLong-term inflammation and recurrent skin infection in recessive dystrophic epidermolysis bullosa (RDEB) are associated with the presence of immunoglobulin A (IgA)-containing immune complexes in the glomerulus. Only eight pediatric RDEB cases with IgA nephropathy (IgAN) have been documented in English-language literature. Most RDEB patients with IgAN progress to kidney failure within 5 years of diagnosis, indicating that these patients may require more intensive early treatment compared to those with primary IgAN. However, diagnosing IgAN in RDEB cases with severe cutaneous manifestations can be challenging. Herein, we report a rare case of nephropathy in an 11-year-old boy with severe RDEB and a frameshift mutation on the COL7A1 gene, which may manifest as kidney disorders. He presented with persistent hematuria and progressing proteinuria. A presumptive IgAN diagnosis was based on clinical features and increased IgA serum levels, as kidney biopsy was refused by his parents. Nephrotic-range proteinuria persisted despite initial steroid and lisinopril treatment. Monthly intravenous cyclophosphamide (IV CPA; 500 mg/m2) led to proteinuria remission and preservation of kidney function for 2 years posttreatment. We conclude that COL7A1 mutations may result in extracutaneous manifestations, including kidney disorders. The association between IgA-containing immune complex deposits in the glomerulus and recurrent skin infection in RDEB may indicate IgAN, particularly when kidney biopsy is infeasible due to severe skin manifestations. In our case, positive results with IV CPA suggest further investigation is needed to explore its potential role in non-rapidly progressing IgAN in children with RDEB.https://beta.karger.com/Article/FullText/530875col7a1cyclophosphamidehematuriaimmunoglobulin a nephropathyimmunosuppressionproteinuriasteroid-resistant children
spellingShingle Cahyani Gita Ambarsari
Retno Palupi-Baroto
Fira Alyssa Gabriella Sinuraya
Elvi Suryati
Etty Widyastuti
Suci Widhiati
Nephropathy in a Child with Severe Recessive Dystrophic Epidermolysis Bullosa Treated with Cyclophosphamide: A Case Report
Case Reports in Nephrology and Dialysis
col7a1
cyclophosphamide
hematuria
immunoglobulin a nephropathy
immunosuppression
proteinuria
steroid-resistant children
title Nephropathy in a Child with Severe Recessive Dystrophic Epidermolysis Bullosa Treated with Cyclophosphamide: A Case Report
title_full Nephropathy in a Child with Severe Recessive Dystrophic Epidermolysis Bullosa Treated with Cyclophosphamide: A Case Report
title_fullStr Nephropathy in a Child with Severe Recessive Dystrophic Epidermolysis Bullosa Treated with Cyclophosphamide: A Case Report
title_full_unstemmed Nephropathy in a Child with Severe Recessive Dystrophic Epidermolysis Bullosa Treated with Cyclophosphamide: A Case Report
title_short Nephropathy in a Child with Severe Recessive Dystrophic Epidermolysis Bullosa Treated with Cyclophosphamide: A Case Report
title_sort nephropathy in a child with severe recessive dystrophic epidermolysis bullosa treated with cyclophosphamide a case report
topic col7a1
cyclophosphamide
hematuria
immunoglobulin a nephropathy
immunosuppression
proteinuria
steroid-resistant children
url https://beta.karger.com/Article/FullText/530875
work_keys_str_mv AT cahyanigitaambarsari nephropathyinachildwithsevererecessivedystrophicepidermolysisbullosatreatedwithcyclophosphamideacasereport
AT retnopalupibaroto nephropathyinachildwithsevererecessivedystrophicepidermolysisbullosatreatedwithcyclophosphamideacasereport
AT firaalyssagabriellasinuraya nephropathyinachildwithsevererecessivedystrophicepidermolysisbullosatreatedwithcyclophosphamideacasereport
AT elvisuryati nephropathyinachildwithsevererecessivedystrophicepidermolysisbullosatreatedwithcyclophosphamideacasereport
AT ettywidyastuti nephropathyinachildwithsevererecessivedystrophicepidermolysisbullosatreatedwithcyclophosphamideacasereport
AT suciwidhiati nephropathyinachildwithsevererecessivedystrophicepidermolysisbullosatreatedwithcyclophosphamideacasereport